Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia-Reference-Cited by-同舟云学术

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia

Published:2022-08-30 Issue:8 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bighelli Irene¹,Rodolico Alessandro²,Siafis Spyridon¹,Samara Myrto T³,Hansen Wulf-Peter⁴,Salomone Salvatore⁵,Aguglia Eugenio²,Cutrufelli Pierfelice²,Bauer Ingrid¹⁶,Baeckers Lio¹,Leucht Stefan¹

Affiliation:

1. Section for Evidence Based Medicine in Psychiatry and Psychotherapy, Department of Psychiatry and Psychotherapy, School of Medicine; Technical University of Munich; Munich Germany

2. Department of Clinical and Experimental Medicine, Psychiatry Unit; University of Catania; Catania Italy

3. Department of Psychiatry, Faculty of Medicine; University of Thessaly; Larisa Greece

4. BASTA - Bündnis für psychisch erkrankte Menschen; Munich Germany

5. Biomedical and Biotechnological Sciences; University of Catania; Catania Italy

6. Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty; University of Augsburg; Augsburg Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Reference149 articles.

1. Switching from 2 antipsychotics to 1 antipsychotic in schizophrenia: a randomized, double-blind, placebo-controlled study;Borlido;Journal of Clinical Psychiatry,2016

2. Antipsychotic polypharmacy in schizophrenia clinicaltrials.gov/ct2/show/NCT00493233

3. Is the risk of antipsychotic polypharmacy discontinuation dependent on the agents used?;Constantine;Psychiatry Research,2018

4. The risks and beneﬁts of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: a randomized controlled trial;Constantine;Schizophrenia Research,2015

5. Effectiveness of switching from antipsychotic polypharmacy to monotherapy;Essock;American Journal of Psychiatry,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and acceptability of interventions to reduce antipsychotic polypharmacy: A systematic review and meta-analysis of randomized clinical trials;Schizophrenia Research;2024-08

2. Association of Antipsychotic Polypharmacy and Two-Year All-Cause Mortality: A Population-Based Cohort Study of 33,221 Italian Continuous Users;Journal of Clinical Medicine;2024-04-03

3. A lifetime of mental health treatments for people with schizophrenia: update and narrative review;Current Opinion in Psychiatry;2024-02-13

4. Pharmacotherapy of schizophrenia: clinical and some age-related aspects;S.S. Korsakov Journal of Neurology and Psychiatry;2024

5. Better adherence to guidelines among psychiatrists providing pharmacological therapy is associated with longer work hours in patients with schizophrenia;Schizophrenia;2023-11-07